Showing 11-16 of 16 results for "".
- ASDSA's 2022 Top Advocates Recognizedhttps://practicaldermatology.com/news/asdsas-2022-top-advocates-recognized/2461381/Meet the American Society for Dermatologic Surgery Association (ASDSA) honorees from the fourth annual Top Advocate program Honorees are chosen based on their contribution to various advocacy efforts throughout the year and demonstrated commitment to patient safety in the field of dermatologic sur…
- Study Identifies 29 New Acne Risk Geneshttps://practicaldermatology.com/news/study-identifies-29-new-acne-risk-genes/2461082/Researchers have identified 29 regions of the genome that influence acne. The new findings may open up new avenues of treatment and help clinicians identify individuals at high risk of severe acne. The research is published in Nature Communications. To arrive at their findings, researchers analyz…
- ASDSA Honorees Recognized for Engagement in Initiatives that Benefit Dermatologic Surgery and Patientshttps://practicaldermatology.com/news/asdsa-honorees-recognized-for-engagement-in-initiatives-that-benefit-dermatologic-surgery-and-patients/2460995/The American Society for Dermatologic Surgery Association (ASDSA) announced the recipients of its annual awards this week during the ASDS / ASDSA Virtual Annual Meeting. ASDSA is proud to recognize its members who contribute significant time and expertise advocating for patient safety, including: …
- LEO Pharma Taps Jörg Möller as EVP, Global Research and Developmenthttps://practicaldermatology.com/news/leo-pharma-taps-jorg-moller-as-evp-global-research-and-development/2460636/Jörg Möller is joining LEO Pharma A/S’s Global Leadership Team as Executive Vice President (EVP), Global Research and Development, effective January 1, 2021. Möller joins LEO Pharma from Bayer Pharma, where he has been EVP Head of R&D and Member of the Bayer Pharma Executive Committee. A medical …
- Cosentyx Shows Early Synovitis Reduction in PsAhttps://practicaldermatology.com/news/cosentyx-shows-early-synovitis-reduction-in-psa/2460600/Cosentyx (secukinumab) showed early reduction of synovitis in psoriatic arthritis (PsA), according to the Phase IIIb ULTIMATE trial which will be presented at the American College of Rheumatology (ACR) All-Virtual Annual Meeting. Specifically, a significant reduction of synovitis was demonstrated …
- Kiwi Skincare Line Comes to US Ulta Storeshttps://practicaldermatology.com/news/kiwi-skincare-line-comes-to-us-ulta-stores/2457793/Trilogy, described as New Zealand's number one natural skincare brand, is now available in Ulta Beauty Stores. Trilogy will be launching in 1,080 of Ulta Beauty's new curated beauty spaces in their prestige skincare department. Five of the brand's most popular products will be showcased in the …
- Previous
- Next